Sanofi-Aventis Korea gains KDRA membership

Published: 2013-08-27 06:56:00

Updated: 2013-08-27 06:56:00

Recently, Sanofi-Aventis Korea, a local unit of Paris-based leading health care company, joined the Korea Drug Research Association (KDRA) as one of the full-fledged members.

The KDRA, established in August 1986, currently has 54 members and 260 research organizations.

Sanofi-Aventis Korea ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK